VIC Fellows Spotlight: Gopesh Tilvawala, PhD

Navigating Investment Opportunities in Medical Devices: A Guide for Savvy Investors

Calyxo Announces FDA Clearance for Second Generation CVAC System

The Ivory Tower’s Secret Mission: Academic to Commercial Translation

William McCoy, PhD, Joins Zebra Analytix's Board of Directors

VIC 2023 Annual Report: Executive Summary

VIC Fellows Spotlight: Jonathan Rayner, PhD

Solenic Medical to Exhibit at the 2024 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in San Francisco

A Letter from our CEO

Part 3: Challenges and Solutions for University Technology Commercialization – Gap Programs

Filtravate Awarded $400,000 LEEP Fellowship Grant From The Department Of Energy

Capitalizing on Medical Knowledge: How Physicians are Shaping Life Sciences Startups Through Investment

Enhance Diagnostics is Developing a Device for At-Home Monitoring of Kidney Diseases

Solenic Medical Unveils the SOLA2 System at the Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS)

Zebra Analytix Launches an Advancement in Analytical Science with MEMS Cluster-Columns

Vixiar Medical's Noninvasive Point of Care Device for Assessing Cardiac Response to Acute Volume Changes

VIC Fellows Spotlight: Sobha Pisharody, PhD

VIC Tech Expands National Footprint Establishing New Office in Minnesota

Dr. Wilbur Lam, Chief Medical Officer of Cellia Science, Elected to the National Academy of Medicine

Inside Pitt Innovation Institute with the Associate Director, Office of Industry & Economic Partnerships Paul-Valentin Pitou

Solenic Medical Appoints Jose F. Guzman as Vice President of Strategic Marketing

Nob Hill Therapeutics Awarded HHS Phase II Grant for Lung Cancer Therapy

Neurexis Therapeutics: New Discoveries Could Revolutionize Treatment of Alzheimer's and Other Neurological Conditions

The Genomic Revolution: Unveiling Personalized Medicine's Investment Potential

Exploring the Clinical Applications of Virtual Reality in Healthcare

FDA Breakthrough Device Designation for High Impact Medical Devices

Cellia Science Awarded Phase I STTR Grant by National Institute of Biomedical Imaging and Bioengineering to Develop Instrument for Bone Marrow Aspiration Adequacy Assessment

VIC Tech Announces New Class of Fellows

SFC Fluidics Inc. Receives $2 Million SBIR Grant to Develop Groundbreaking Dual Hormone System for Diabetes Care

VIC 2023 Mid-Year Report

Solaris Vaccines Awarded Funding from NIH to Develop Novel Influenza Vaccine using SolaVAX™ Platform

Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.

The Advantages of Investing in Venture Creation Firms Like VIC Tech

Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager

Nob Hill Therapeutics Selected for Featured Poster Presentation at Respiratory Innovation Summit

VIC Foundry Awarded Phase I SBIR Grant from the National Institutes of Health

Direct-to-Phase II SBIR Grant from NIH Awarded to Neurexis Therapeutics to Evaluate Neuroprotective Therapeutic in Stroke Preclinical Assessment Network (SPAN)

Solaris Vaccines Adds Izabela Ragan as Director of Research and Development for the SolaVAX™ Platform

Intellectual Property Landscape Analysis Using Free Patent Databases

Due Diligence for Life Science Investments

From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.

Cellia Science Awarded National Institutes of Health Phase I SBIR Funding

VIC Fellows Spotlight: Matthew Leming, PhD

VIC 2022 Annual Report Executive Summary

VIC Tech Adds Chantell Preston to Board of Directors

A Letter from our CEO

A New Tech Helping Enable Telemedicine

VIC Fellows Spotlight: Mark Jarboe, MBA

Our Life Science and Healthcare Future

From the Corner Office: Cellia Science

Part 2: Challenges and Solutions for University Technology Commercialization - License Terms

CardioWise Named Rising Star at the UCSF Health Awards

Inside the OTT at Emory University with Associate Vice President of Research and Executive Director Todd Sherer, PhD

CardioWise, Inc. Named a Finalist in the Rising Star Clinical Diagnostics Tool or Platform Category by UCSF Health Hub

Tesseract Structural Innovations Partners with Cymat in APMA Electric Vehicle Project Arrow

Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board

VIC Fellows Spotlight: Danielle France, PhD

Dr. Davies-Cutting Brings Industry Leading Technical Expertise to Nob Hill Therapeutics

Individual Investor Access to VC Stage Investments

Filtravate Awarded National Science Foundation SBIR Phase I Grant

VIC Foundry Awarded an NIH Grant for Development of Instrument for Ultrafast Detection of Protein Biomarkers

MedTech Development Built Upon Outstanding Medical Advice

Nob Hill Therapeutics Awarded HHS Phase II Grant and Announces New CEO

VIC Tech Continues to Grow Its Medical Advisory Board

Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio

VIC Fellows Spotlight: Alexandra Antonioli, MD, PhD

CardioWise, Inc. Selected for the Inaugural Edison Accelerator By GE Healthcare in Collaboration with Nex Cubed

VIC 2022 Mid-Year Update Executive Summary

Inside CTTC at Vanderbilt University with Assistant Director, Physical Sciences Ashok Choudhury

VIC Tech Announces New Class of Fellows

Cellia Science Announces Dr. Wilbur Lam as Chief Medical Officer

CardioWise Joins the Lucem Health Innovation Collaborative as a Founding Member

Part 1: Challenges and Solutions for University Technology Commercialization

VIC Tech Grows Its Medical Advisory Board

From the Corner Office: Filtravate

Cellia Science Formed to Develop and Commercialization Point-of-Care Hematology Analyzers

VIC Fellows Spotlight: Cristhiaan Ochoa, MD, PhD

SAFE vs. Convertible Notes: Which is a Better Choice for Early-Stage Investments?

Solenic CEO James Lancaster presents at the LSI Emerging Medtech Summit

From the Corner Office: Neurexis Therapeutics

Inside CSURF with Managing Director, Steve Foster

Filtravate Highlighted by The Business Journals

VIC Fellows Spotlight: Gurshagan Kandhola, PhD

VIC 2021 Annual Report Executive Summary

VIC Technology Venture Development Establishes Medical Advisory Board

Letter from the CEO

Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity

VIC Fellows Spotlight: Kelly Mabry, PhD

VIN Partner Profile: Carol Reeves

Nob Hill Therapeutics Announces Strategic Advisory Board to Accelerate Growth

Inside UCSF Innovation Ventures with Executive Director, Anthony Francis

VIC Technology Venture Development Adds Laura Lyons to Board of Directors

Nob Hill Therapeutics to Present at Partnership Opportunities in Drug Delivery (PODD) Conference

Akeso Biomedical Receives EU Authorization for CI-FER® as a Feed Additive in Piglets

Impact Investing in Healthcare

Future Forward: Health Innovators Launch Inventions Prompted by the Pandemic

VIC Fellows Spotlight: Secondra Holmes, PhD

Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic

Nob Hill Therapeutics Selected as a Finalist for RESI Innovator’s Pitch Challenge

CardioWise Named Quarterfinalists at the UCSF Health Awards

University Technology Licensing Part 2: Assessing the Opportunities and Negotiating Licenses

Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform

VIC Fellows Spotlight: Evan Goldberg, PhD

University Technology Licensing: Assessing the Opportunities and Negotiating Licenses

Tesseract Structural Innovations Receives Two New US and WO Patents

VIC 2021 Mid-Year Update Executive Summary

VIC Technology Venture Development Announces New Board of Directors Appointment

Inside Blackstone LaunchPad at UT Southwestern Medical Center with Brad Phelan

Building Life Science Startups Beyond Traditional Venture Capital Hubs

Filtravate Highlighted by New Mexico State University

VIC Fellows Spotlight: Michael Gaspar, MD

Zebra Analytix Appoints John A. Michalek as CEO

Zero Federal Capital Gains Taxes on High-Return Investments

Solenic Medical Wins Big at the 2021 Texas A&M New Ventures Competition

Protecting Early Investors in Capital-Intensive Life Science Companies

Behind the Curtain | Single Family Offices and ESG Investing with Brian Cork

VIC Announces Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation

Nob Hill Therapeutics Adds Seasoned Life Science Expert Paul Atkins as Executive Chairman

The Accelerating Pace of Life Science Innovation in a (Soon-to-Be) Post-Pandemic World

Akeso Biomedical Announces European Food Safety Authority Positive Scientific Opinion

VIC Technology Venture Development Announces New Board of Directors Appointment

Inside CU Innovations: An Interview with Executive Director, Kim Muller

From the Corner Office: Solenic Medical Reaches a Two-Year Anniversary Milestone

Zebra Analytix Receives NIH Grant for Rapid Breath Detection of Hazardous Substance Exposure

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

VIC 2020 Annual Report Executive Summary

VIC Fellows Spotlight: Kirt Gill, MD

Diabeloop SA and SFC Fluidics Announce Development Agreement

CardioWise Receives US FDA 510(k) Clearance for Heart Function Analysis Software

A Letter from our CEO

Neurexis Therapeutics Works to Solve an Unmet Healthcare Need

VIC Investor Network Introduces a Secondary Market for Members

SFC Fluidics, Inc. Receives FDA Breakthrough Device Designation

VIC Portfolio Company, BlueInGreen, Acquired by Chart Industries

Inside The VIC Fellows Program

VIC Fellows Spotlight: Travis Nemkov, PhD

Tesseract Structural Innovations and Cymat Technologies Announce Co-Operation Agreement

VIC Foundry: An Incubator for High Impact Life Science Technologies

Sustainability as Strategy: A Discussion with BlueInGreen

VIC Fellow Spotlight: Dr. Greg Tucker

Partner Spotlight: OmniValley

The Anatomy of a Friends and Family Round in a COVID-19 World

Opportunity Assessment: How To Vet So Much Tech

Solenic Medical Receives FDA Breakthrough Device Designation

Partner Spotlight: SeedSprint

VIC 2020 Mid-Year Update

Vixiar: Solving a Big Problem With a Small Device

Portfolio Diversification in Times of Market Volatility

The Emerging Remote Workplace: Digital Best Practices for Investor Groups

Neurexis Therapeutics Awarded Colorado Advanced Industries Accelerator Grant

Zebra Analytix Awarded NIH Funding to Improve Workplace Safety

VIC Fellow Spotlight: Dr. Natalie Gassman

Why VIC Sometimes Steps Outside Its Life Science Focus

CardioWise Makes FDA Submission With Request for Expedited Approval for COVID-19

Enjoy The Ride: Inside an Automotive Startup

BlueInGreen Uses Wastewater Treatment Technology to Fight COVID-19

VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact

From The Corner Office: SFC Fluidics Nears FDA Submission

VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics

VIC Launches New Fellows Program

VIC Technology Venture Development Forms New Portfolio Company: Filtravate

Failing to fundraise can be the downfall of startups

An Interview with Darlene Boudreaux: CEO, Investor, and Entrepreneur

VIC 2019 Annual Report

Behind the Curtain with Biolocity | Guiding Medical Innovations to Market

White Paper: New Paradigms of Life Science Investing

A Letter from our CEO 2020

Behind the Curtain: Opportunity Assessment at VIC

White Paper: Life Science Impact Investing and the Physician Entrepreneur

An Interview With Nichole Mercier, Office Of Technology Management At Washington University

CardioWise, a Top-Ten Finalist in Best Cardiovascular Digital Diagnostic

Houston Innovation Map: 3 Houston Innovators to Know This Week

VIC New Mexico Regional Office Profile: An Interview With Yun Li

VIC Highlighted by Houston Innovation Map

From The Corner Office: Akeso Biomedical Nears Commercial Sales Stage

White Paper: Avoiding Herd Mentality - Sourcing Quality Innovation Beyond The VC Hot Zones

VIC Forms New Portfolio Company, Solenic Medical

VIN Partner Profile: An Interview With Arlen Meyers

Expanded VIC Investor Network (VIN)

White Paper: Accessing Innovation Directly From The Source - The Growing Trend Of Venture Capital Company Formation

Zebra Analytix Receives Phase I SBIR Award From The National Institutes Of Health

SFC Fluidics® Partners with PercuSense and Diabeloop to Improve Diabetes Care

Zebra Analytix Awarded Competitive Grant From The National Science Foundation

VIC Adds Dr. Michael Artinger As EVP And Managing Director Of New Colorado Office

Dr. Yun Li Joins VIC as Managing Director – New Mexico Branch

James Y. Lancaster Joins VIC Technology Venture Development as Managing Director – Texas Branch

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.